By Editor

I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…

Search Stock Profiles

Latest News

META: Meta Platforms Stock – Buy or Sell This Social Star?

Meta Platforms (META) is the social media diva turned AI visionary, voguing at $585.71 (StockAnalysis.com) as…

By Editor

GOOGL: Alphabet Stock – Buy or Sell This Search Superstar?

Alphabet (GOOGL/GOOG) is the brainy nerd running the internet, lounging at $167.68 (MacroTrends) as of March…

By Editor

How Retail Investors Outplayed Wall Street in April

Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…

By Editor

How Retail Investors Outplayed Wall Street in April

Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…

By Editor

The Auction Heard ‘Round Wall Street

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…

By Editor

AMGN: Amgen – Buy or Sell This Biotech Bruiser?

Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+ market cap as of…

By Editor
2 Min Read

REGN: Regeneron Pharmaceuticals – Buy or Sell This Biotech Brainiac?

Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a $103 billion market cap…

By Editor
2 Min Read

VRTX: Vertex Pharmaceuticals – Buy or Sell This Biotech Beast?

Vertex Pharmaceuticals (VRTX) is the biotech jungle’s roaring lion, lounging at $485.58 (StockAnalysis.com) with a market cap north of $125…

By Editor
3 Min Read